Angiotensin-converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus and its relationship with diabetic nephropathy

Kidney International

Volumn 52, Issue 2, 1997, Pages 473-477

  Jeffers, Barrett W ^b   Estacio, Raymond O ^b   Raynolds, Mary V ^b   Schrier, Robert W ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b NONE

Author keywords

Angiotensin converting enzyme; Blood pressure and diabetes; Diabetic nephropathy; Genotype ACE DD and diabetes; NIDDM

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ARTICLE; CORONARY ARTERY DISEASE; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEINURIA; RISK ASSESSMENT;

EID: 0030740809     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.355     Document Type: Article

References (32)

1. NATIONAL DIABETES DATA GROUP: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
2. HARRIS MI, HADDEN WC, KNOWLER WC, BENNETT PH: Prevalence and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 years. Diabetes 36:523-534, 1987
3. Proceedings from the Conference on Measuring, Managing, and Improving Quality in the End-Stage Renal Disease Treatment Setting. Am J Kid Dis 24:228-388, 1994
4. MARRE M, BERNADET P, GALLOIS Y, SAVAGNER F, GUYENE TT, HALLAB M, CAMBIEN F, PASSA P, ALHENC-GELAS F: Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 43:384-388, 1994
5. RIGAT B, HUBERT C, ALHENC-GELAS F, CAMBIEN F, CORVOL P, SOUBRIER F: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346, 1990
6. TIRET L, RIGAT B, VISVIKIS S, BREDA C, CORVOL P, CAMBIEN F, SOUBRIER F: Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51:197-205, 1992
7. COSTEROUSSE O, ALLEGRINI J, LOPEZ M, ALHENC-GELAS F: Angiotensin I-converting enzyme in human circulating mononuclear cells: Genetic polymorphism of expression in T lymphocytes. Biochem J 290:33-40, 1993
8. CAMBIEN F, COSTEROUSSE O, TIRET L, POIRIER O, LECERF L, GONZALES MF, EVANS A, ARVEILER D, CAMBOU JP, LUC G, RAKOTOVAO R, DUCIMETIERE P, SOUBRIER F, ALHENC-GELAS F: Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation 90:669-676, 1994
9. RAYNOLDS MV, BRISTOW MR, BUSH EW, ABRAHAM WT, LOWES BD, ZISMAN LS, TAFT CS, PERRYMAN MB: Angiotensin-converting enzyme DD genotype in patients with ischaemic dilated cardiomyopathy. Lancet 342:1073-1075, 1993
10. FUJISAWA T, IKEGAMI H, SHEN GQ, YAMATO E, TAKEKAWA K, NAKAGAWA Y, HAMADA Y, UEDA H, RAKUGI H, HIGAKI J: Angiotensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care 18:983-985, 1995
11. MIZUIRI S, HEMMI H, INOUE A, YOSHIKAWA H, TANEGASHIMA M, FUSHIMI T, ISHIGAMI M, AMAGASAKI Y, OHARA T, SHIMATAKE H, HASEGAWA A: Angiotensin-converting enzyme polymorphism and development of diabetic nephropathy in non-insulin dependent diabetes mellitus. Nephron 70:455-459, 1995
12. SCHRIER RW, SAVAGE S: Appropriate blood pressure control in diabetes (ABCD) trial: Implications for complications. Am J Kid Dis 6:653-657, 1992
13. SAVAGE S, JOHNSON-NAGEL N, ESTACIO RO, FEIG PU, MACCARTHY EP, LOKKEN NJ, ZIEGLER R, SCHRIER RW: The ABCD (appropriate blood pressure control in diabetes) trial: Rationale and design of a trial of hypertension control (moderate or intensive) in type II diabetes. Online J Clin Trials 2:1993
14. WHO STUDY GROUP: Diabetes Mellitus - Technical Report Series 727. Geneva, World Health Organization, 1985
15. KLENK DC: Determination of glycosolated hemoglobin by affinity chromotography: Comparison with calometric and ion exchange methods and effects of common interferences. Clin Chem 28:2088-2094, 1982
16. FOSSATI P, DRENCIPE L: Serum triglycerides determined calorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 28:2077-2080, 1982
17. ALLAIN CC, POON LS, CHAN CS, RICHMOND V, FU PC: Enzymatic determination of total serum cholesterol. Clin Chem 20:470-474, 1973
18. ASSMAN G, SCHRIEWER H, SCHMITZ G, HASCLE E: Quantification of high-density lipoprotein cholesterol by precipitation with phosphoungstic acid. MG CLE (abstract). Clin Chem 29:6, 1983
19. HILBOURNE LH, LIN PC, HIGGINS SA, RODGERSON DO: Evaluation of the Behring nephelometer for detection of low level urinary albumin. Am J Clin Palhol 93:405-410, 1990
20. HOFELDT FD: Diabetes and dyslipidemia disorders in the elderly, in Ethical Issues in the Care of the Elderly (3rd ed.) edited by JAHNIGEN D, SCHRIER RW, Boston, Blackwell Science, 1996
21. IWAI N, OHMICHI N, NAKAMURA Y, KINOSHITA M: DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 90:2622-2628, 1994
22. CAMBIEN F, POIRIER O, LECERF L, EVANS A, CAMBOU JP, ARVEILER D, LUC G, BARD JM, BARA L, RICARD S, TIRET L, AMOUYEL P, ALHENC-GELAS F, SOUBRIER F: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-644, 1992
23. TIRET L, KEE F, POIRIER O, NICAUD V, LECERF L, EVANS A, CAMBOU JP, ARVEILER D, LUC G, AMOYEL P: Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet 341:991-992, 1993
24. LUDWIG EH, CORNELL PS, ANDERSON JF, MARSHALL HW, LALOEL JM, WARD RH: The ACE insertion/deletion polymorphism is independently associated with myocardial infarction and body mass index but not with stenosis (abstract). Circulation 88(Suppl I):I-364, 1993
25. RUIZ J, BLANCHE H, COHEN N, VELHO G, CAMBIEN F, COHEN D, PASSA P, FROGUEL P: Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 91:3662-3665, 1994
26. DORIA A, WARRAM JH, KROLEWSKI AS: Genetic prediposition to diabetic nephropathy: Evidence for a role of the angiotensin I-converting enzyme gene. Diabetes 43:690-695, 1994
27. SCHMIDT S, SCHONE N, RITZ E, DIABETIC NEPHROPATHY STUDY GROUP: Association of ACE gene polymorphism and diabetic nephropathy? Kidney Int 47:1176-1181, 1995
28. KLEIN R, KLEIN BE, MOSS SE: Prevalence of gross microalbuminuria in older-onset diabetes. Diabetes Care 16:1325-1330, 1993
29. DECKERT T, KOFOED-ENEVOLDSEN A, NORGAARD K, BORCH-JOHNSEN K, FELDT-RASMUSSEN B, JENSEN T: Microalbuminuria. Diabetes Care 15:1181-1191, 1992
30. GALL MA, ROSSING P, SKOTT P, DAMSBO P, VAAG A, BECH K, DEJGAARD A, LAURITZEN M, LAURITZEN E, HOUGAARD P: Prevalence of micro and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin dependent) diabetic patients. Diabetologia 34:655-661, 1991
31. MAUER M, MOGENSEN CE, FRIEDMAN EA: Diabetic nephropathy, in Diseases of the Kidney (6th ed) edited by SCHRIER RW, GOTTSHELF CW, Boston, Saunders, 1996
32. ZMOHRNDRN VR, CHRISTENSEN CK: Predicting diabetic nephropathy in insulin dependent patients. N Engl J Med 311:89-93, 1984